BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8884425)

  • 41. The role of recombination activating gene (RAG) reinduction in thymocyte development in vivo.
    Yannoutsos N; Wilson P; Yu W; Chen HT; Nussenzweig A; Petrie H; Nussenzweig MC
    J Exp Med; 2001 Aug; 194(4):471-80. PubMed ID: 11514603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of transfected mutant and wild type RAG genes in different cell types.
    Döbbeling U
    Immunol Invest; 1996; 25(5-6):469-79. PubMed ID: 8915684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TCR deep sequencing of transgenic RAG-1-deficient mice reveals endogenous TCR recombination: a cause for caution.
    McGuire HM; Watkins TS; Field M; Taylor S; Yasuyama N; Farmer A; Miles JJ; Fazekas de St Groth B
    Immunol Cell Biol; 2018 Jul; 96(6):642-645. PubMed ID: 29573470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency.
    Ito T; Sendai Y; Yamazaki S; Seki-Soma M; Hirose K; Watanabe M; Fukawa K; Nakauchi H
    PLoS One; 2014; 9(12):e113833. PubMed ID: 25437445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dispensable sequence motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination.
    Silver DP; Spanopoulou E; Mulligan RC; Baltimore D
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6100-4. PubMed ID: 8327489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The RAG recombinase: Beyond breaking.
    Lescale C; Deriano L
    Mech Ageing Dev; 2017 Jul; 165(Pt A):3-9. PubMed ID: 27863852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of RAG expression in developing lymphocytes.
    Nagaoka H; Yu W; Nussenzweig MC
    Curr Opin Immunol; 2000 Apr; 12(2):187-90. PubMed ID: 10712943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different developmental arrest points in RAG-2 -/- and SCID thymocytes on two genetic backgrounds: developmental choices and cell death mechanisms before TCR gene rearrangement.
    Diamond RA; Ward SB; Owada-Makabe K; Wang H; Rothenberg EV
    J Immunol; 1997 May; 158(9):4052-64. PubMed ID: 9126963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutive Bcl-2 expression during immunoglobulin heavy chain-promoted B cell differentiation expands novel precursor B cells.
    Young F; Mizoguchi E; Bhan AK; Alt FW
    Immunity; 1997 Jan; 6(1):23-33. PubMed ID: 9052834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human RAG mutations: biochemistry and clinical implications.
    Notarangelo LD; Kim MS; Walter JE; Lee YN
    Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombination activating genes (RAG) induce secondary Ig gene rearrangement in and subsequent apoptosis of human peripheral blood circulating B lymphocytes.
    Nagafuchi H; Yoshikawa H; Takeba Y; Nara K; Miura K; Kurokawa MS; Suzuki N
    Clin Exp Immunol; 2004 Apr; 136(1):76-84. PubMed ID: 15030517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different expression of the recombination activity gene RAG-1 in various populations of thymocytes, peripheral T cells and gut thymus-independent intraepithelial lymphocytes suggests two pathways of T cell receptor rearrangement.
    Guy-Grand D; Vanden Broecke C; Briottet C; Malassis-Seris M; Selz F; Vassalli P
    Eur J Immunol; 1992 Feb; 22(2):505-10. PubMed ID: 1537384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity.
    Wiler R; Leber R; Moore BB; VanDyk LF; Perryman LE; Meek K
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11485-9. PubMed ID: 8524788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of V(D)J recombination by RAG1 and RAG2.
    Oettinger MA
    Trends Genet; 1992 Dec; 8(12):413-6. PubMed ID: 1492366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The half-life of RAG-1 protein in precursor B cells is increased in the absence of RAG-2 expression.
    Grawunder U; Schatz DG; Leu TM; Rolink A; Melchers F
    J Exp Med; 1996 Apr; 183(4):1731-7. PubMed ID: 8666930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of DNA-dependent protein kinase holoenzyme upon induction of lymphocyte differentiation and V(D)J recombination.
    Grawunder U; Finnie N; Jackson SP; Riwar B; Jessberger R
    Eur J Biochem; 1996 Nov; 241(3):931-40. PubMed ID: 8944785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Definition of a core region of RAG-2 that is functional in V(D)J recombination.
    Sadofsky MJ; Hesse JE; Gellert M
    Nucleic Acids Res; 1994 May; 22(10):1805-9. PubMed ID: 8208603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The RAG-2 Inhibitory Domain Gates Accessibility of the V(D)J Recombinase to Chromatin.
    Ward A; Kumari G; Sen R; Desiderio S
    Mol Cell Biol; 2018 Aug; 38(15):. PubMed ID: 29760281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exclusion and inclusion of alpha and beta T cell receptor alleles.
    Borgulya P; Kishi H; Uematsu Y; von Boehmer H
    Cell; 1992 May; 69(3):529-37. PubMed ID: 1316241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of RAG gene expression in normal and transformed precursor lymphocytes.
    Rathbun G; Oltz EM; Alt FW
    Int Immunol; 1993 Aug; 5(8):997-1000. PubMed ID: 8398992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.